A practical reference on actin binding: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2026-04-16. Anything still debated is marked as such rather than presented as settled.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
TB-500 is a laboratory label applied to a short synthetic peptide that is widely described as a fragment of thymosin beta-4, an actin-binding protein present in most mammalian cells. Suppliers and review articles usually present TB-500 as the N-terminal region of that protein, but the exact sequence attached to the name is not consistent across sources. Some product descriptions list a seven-residue chain; others use the label loosely for the parent protein itself. Because of that variation, any technical discussion of TB-500 needs to state which sequence is meant.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
| Property | Value | Notes |
|---|---|---|
| Purity determination | Reversed-phase HPLC | UV detection commonly at 214 nm |
| Mass confirmation | Mass spectrometry | Compared against theoretical 888.5 Da |
| Powder storage | -20 C or below | Dry and protected from light |
| Reconstituted storage | Aliquoted and frozen | Avoid repeated freeze-thaw cycles |
| Reconstitution solvent | Sterile water or neutral buffer | Avoid extreme pH conditions |
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
Laboratory work on thymosin beta-4 describes binding to monomeric actin and effects on cell migration, angiogenesis, and inflammatory signaling in cultured cells. Animal models have examined skin, corneal, and cardiac repair after injury, with outcomes reported mainly in preclinical literature. Most of that evidence concerns the parent protein rather than preparations labelled TB-500, so extrapolation from animal findings to a specific commercial product remains uncertain. Whether the two behave identically in living systems has not been established in controlled human studies.
Identity and purity are checked with chromatographic and mass spectrometric methods. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities, while mass spectrometry confirms the expected molecular mass. A certificate of analysis may report a purity percentage, but the laboratory should still verify the material independently. Common quality concerns include truncated sequences, deamidation, oxidation, and residual solvents from synthesis. Because TB-500 is short, some impurities can differ from the target by only a few mass units.
Reconstitution practices affect downstream measurements. The dry powder is typically dissolved in sterile water or a suitable aqueous buffer, then mixed gently rather than vortexed at high speed. Visible particles or cloudiness suggest incomplete dissolution or contamination and should be investigated. For long-term storage, aliquots should be labeled with concentration, solvent, and date. Open questions include how different buffers alter peptide conformation and whether specific container materials adsorb the peptide. Those variables can change apparent concentration in assays even when the chemical identity is correct.
Lyophilized TB-500 is hygroscopic and should be kept dry before use. The usual storage recommendation for the solid is -20 °C, protected from light and moisture. Once dissolved, the peptide is less stable, and repeated freeze-thaw cycles can promote aggregation or degradation. Laboratories often divide a reconstituted solution into single-use aliquots and store them at -80 °C. Exact stability limits depend on buffer, pH, and concentration, so published data do not define a single universal condition.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Identity and purity are checked with reversed-phase high-performance liquid chromatography, which separates the target sequence from truncated or deletion analogues, and with mass spectrometry, which confirms the expected molecular mass. Amino acid analysis and peptide mapping give orthogonal confirmation but are used less often outside specialist laboratories. Counter-ion content varies: material purified on trifluoroacetic acid gradients retains trifluoroacetate, and ion exchange can convert the salt form. Residual water and solvent are measured by Karl Fischer titration or thermogravimetric analysis, and any purity figure should be read together with the method used to obtain it.
Lyophilised peptide powders are hygroscopic, and the fragment absorbs atmospheric moisture when a vial is opened at room temperature. Weighing and aliquoting are normally done quickly in a dry environment, and stock solutions are divided into single-use portions before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and can shift the measured content of a vial. These practices are general to synthetic peptides rather than unique to this sequence, but they matter more for short chains kept for long periods.
Idrees Kahloon, "Border Control: The economics of immigration vs. the politics of immigration", The New Yorker, 12 June 2023, pp. 65–69. "The limits of immigration are not set by economics but by political psychology – by backlash unconcerned with net benefits." (p. 65.) Susan Harbage Page & Inéz Valdez (17 April 2011). "Residues of Border Control", Southern Spaces James, Paul (2014). "Faces of Globalization and the Borders of States: From Asylum Seekers to Citizens". Citizenship Studies. 18 (2): 208–23. doi:10.1080/13621025.2014.886440. S2CID 144816686. Philippe Legrain (2007). Immigrants: Your Country Needs Them, Little Brown, ISBN 0-316-73248-6 Aristide Zolberg (2006). A Nation by Design: Immigration Policy in the Fashioning of America, Harvard University Press, ISBN 0-674-02218-1 Philippe Legrain (2007). Immigrants: Your Country Needs Them, Little Brown, ISBN 0-316-73248-6 Ruben Rumbaut & Walter Ewing (Spring 2007). "The Myth of Immigrant Criminality and the Paradox of Assimilation: Incarceration Rates among Native and Foreign-Born Men", The Immigration Policy Center. Bryan Balin (2008). State Immigration Legislation and Immigrant Flows: An Analysis The Johns Hopkins University Douglas S. Massey (September 2005). "Beyond the Border Buildup: Towards a New Approach to Mexico-U.S. Migration", Immigration Policy Center, the American Immigration Law Foundation IPC Special Report (November 2005). "Economic Growth & Immigration: Bridging the Demographic Divide", Immigration Policy Center, the American Immigration Law Foundation American Immigration Council (April 2014).
Aside from drug encapsulation, DNA Legos have many other potential applications including molecular probes for biological studies, rendering spatial control for biosynthesis, and to allow for rapid nanofabrication of complex inorganic molecules. The modularity of the bricks and their ability to self assemble one at a time allows for rapid prototyping and fabrication. The DNA bricks are composed of short synthetic DNA strands thus these strands can be modified to have desirable characteristics or interactions with other molecules. Furthermore, polymers including L-DNA could be used to achieve designer chemical properties allowing for diverse applications of DNA Legos. The ability of the bricks to have tunable shapes and chemical properties contributes to the versatility of DNA Legos as a platform for engineering highly customizable nanoscale systems.
This incident made me feel sad, though many Chinese have been understanding. It disclosed many problems for government and company supervision of the milk sources, quality and marketing administration ... The government will put more efforts into food security, taking the incident as a warning. What we are trying to do is to ensure no such event happens in future by punishing those leaders as well as enterprises responsible. None of those companies without professional ethics or social morals will be let off. On 1 October, CPC general secretary Hu Jintao noted the importance of food safety to the public, and said that "Chinese companies should learn from the lessons of the Sanlu tainted milk powder incident." On 6 October 2008, putting the blame on "illegal production and greed", the country's "chaotic dairy production and distribution order", and the "gravely absent supervision" for the crisis, the State Council announced new dairy industry regulations. In response to the crisis, the State Council of China issued the "Regulations on the Supervision and Administration of Dairy Product Quality and Safety" on October 10, 2008, to regulate the production, processing, packaging and sales of dairy products, thereby ensuring content and quality compliance. On November 19, 2008, the State Council promulgated the "China Dairy Industry Reorganization and Revitalization Plan" to rectify the chaos in China's dairy industry.
Corticosteroids: Produced by the adrenal cortex, these hormones regulate stress responses, electrolyte balance, and immune function. Glucocorticoids: Involved in carbohydrate metabolism, anti-inflammatory actions, and immunosuppression. Cortisol, which increases blood glucose levels during stress and suppresses immune activity to prevent excessive inflammation. Mineralocorticoids: Control salt and water balance to maintain blood pressure. Aldosterone, which promotes sodium reabsorption in the kidneys, thereby regulating extracellular fluid volume. Sex steroids: Derived mainly from the gonads and adrenal glands, these influence sexual development, reproduction, and secondary sexual characteristics. Progestogens: Essential for preparing the reproductive system for pregnancy. Progesterone, which supports implantation and sustains early pregnancy by maintaining the uterine lining. Androgens: Promote male reproductive development and maintenance. Testosterone, which drives spermatogenesis and the growth of male secondary sex characteristics such as muscle mass and facial hair. Estrogens: Key to female reproductive cycles and skeletal health. Estradiol, which stimulates endometrial proliferation during the menstrual cycle and contributes to bone density. Other steroids extend beyond hormonal roles and include compounds involved in neuroprotection, digestion, and neuromuscular activity:
=== Conditionally essential === Conditionally essential nutrients are certain organic molecules that can normally be synthesized by an organism, but under certain conditions in insufficient quantities. In humans, such conditions include premature birth, limited nutrient intake, rapid growth, and certain disease states. Inositol, taurine, arginine, glutamine and nucleotides are classified as conditionally essential and are particularly important in neonatal diet and metabolism.
Sources: en.wikipedia.org
==== Administering the department ==== Although the Ministry of Defence already had its own "Management Audit" system, Heseltine insisted on introducing his own version of the MINIS system which he had introduced at the Environment. The Ministry of Defence had a budget of £17 million per annum, and employed 246,000 civilians as well as 300,000 in uniform. Whereas the Department of the Environment had 66 directorates, Defence had 156, each headed by a two-star officer or a civil servant of equivalent seniority. The organisation chart took months to design and covered four large sheets of paper. In the event Heseltine was too preoccupied by the political matters to pay much attention to the MINIs reports which had taken so long to produce. Heseltine disliked dealing with paperwork, and insisted on having plenty of time to take decisions, and that all reports sent to him had to be first run past one of his advisers for comments. Staff numbers fell by 20,000 (one in twelve) during Heseltine's time at Defence, and many services were privatised, including the Royal Ordnance Factories whilst the Royal Navy Dockyards at Devonport and Rosyth were put under private management. The three separate service ministries (Admiralty, War and Air) had merged into a single Ministry of Defence in 1981. Heseltine drew up plans on a flight back from Kuwait to merge the services further, so that the three chiefs of staff reported directly to the Chief of Defence Staff instead of being treated as colleagues, whilst some supply services were to be merged.
== Applications == DTT is used as a reducing or "deprotecting" agent for thiolated DNA. The terminal sulfur atoms of thiolated DNA have a tendency to form dimers in solution, especially in the presence of oxygen. Dimerization greatly lowers the efficiency of subsequent coupling reactions such as DNA immobilization on gold in biosensors. Typically DTT is mixed with a DNA solution and allowed to react, and then is removed by filtration (for the solid catalyst) or by chromatography (for the liquid form). The DTT removal procedure is often called "desalting." Generally, DTT is used as a protecting agent that prevents oxidation of thiol groups. DTT is frequently used to reduce the disulfide bonds of proteins and, more generally, to prevent intramolecular and intermolecular disulfide bonds from forming between cysteine residues of proteins. However, even DTT cannot reduce buried (solvent-inaccessible) disulfide bonds, so reduction of disulfide bonds is sometimes carried out under denaturing conditions (e.g., at high temperatures, or in the presence of a strong denaturant such as 6 M guanidinium chloride, 8 M urea, or 1% sodium dodecylsulfate). DTT is oftentimes used along with sodium dodecylsulfate in SDS-PAGE to further denature proteins by reducing their disulfide bonds to allow for better separation of proteins during electrophoresis. Because of the ability to reduce disulfide bonds, DTT can be used to denature CD38 on red blood cells. DTT will also denature antigens in the Kell, Lutheran, Dombrock, Cromer, Cartwright, LW and Knops blood group systems.
Valdecoxib is a nonsteroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a selective cyclooxygenase-2 inhibitor. It was patented in 1995. Valdecoxib was manufactured and marketed under the brand name Bextra by G. D. Searle & Company as an anti-inflammatory arthritis drug. It was approved by the United States Food and Drug Administration (FDA) on November 20, 2001, to treat arthritis and menstrual cramps, and was available by prescription in tablet form until 2005 when the FDA requested that Pfizer (Searle's parent company) withdraw Bextra from the American market. The FDA cited "potential increased risk for serious cardiovascular (CV) adverse events," an "increased risk of serious skin reactions" and the "fact that Bextra has not been shown to offer any unique advantages over the other available NSAIDs." In 2009, Bextra was at the center of the "largest health-care fraud settlement and the largest criminal fine of any kind ever." Pfizer paid a $2.3 billion civil and criminal fine. Pharmacia & Upjohn, a Pfizer subsidiary, violated the United States Food, Drug and Cosmetic Act for misbranding Bextra "with the intent to defraud or mislead." A water-soluble and injectable prodrug of valdecoxib, parecoxib, is marketed in the European Union under the tradename Dynastat.
Produced by Peter Goodchild, directed by Bryn Higgins (the mock-documentary looked like an episode of Casualty, which he would later direct), made by Stone City Films 14 July Russian Roulette, about the early warning system in operation over Russia; 25 January 1995 over the Barents Sea, an object is detected, which at first looks like a missile, but after 8 minutes falls into the sea - it was a Norwegian rocket, and the Russians had been notified of the launch weeks before, but had not told their radar units; Bruce G. Blair, a nuclear security writer from the Brookings Institution; Colonel Robert Bykov of the Strategic Rocket Forces of Russia; Alexander Pikayev of the State Duma Defence Committee; Admiral Stansfield Turner of the United States Navy; General Eugene E.
Pompilidotoxins (PMTXs) are toxic substances that can only be found in the venom of several solitary wasps. This kind of wasp uses their venom to offensively capture prey and is relatively harmless to humans. This is in stark contrast to social insects that defend themselves and their colonies with their venom. The pompilidotoxin producing wasps are part of the Pompilinae subfamily which consists of fifty known genus groups of which only two groups are known to produce the toxin. Both groups produce different variants. The first notice of a pompilidotoxin variant was made by Konno et.al in 1997 after a survey was conducted of neurotoxins in solitary wasps that inhabit Japan. He purified and synthesised this toxin, now called α-pompilidotoxin from the solitary spider wasp (Anoplius samariensis). The second, closely related variant, β-pompilidotoxin, was found by Konno et.al. a year later in 1998 in another solitary wasp (Batozonellus maculifrons) In this year Konno et.al. also shed concrete light on the structure and function of these toxins. Anoplius samariensis is known to live distributed over the globe with reported cases in east-Asia, east and central Europe, and Russia. It produces the α-PMTX to act upon the nervous system of a stung victim. This way they can paralyse a wide range of spiders that will then be dragged to the wasp's nest that is located in the ground, in a cavity of a plant stem, or made from mud. The spider wasp lays its eggs on paralysed spiders so that the hatching larvae can feed on living prey.
Sources: en.wikipedia.org
The lyophilised powder is typically held at -20 C or lower in a dry, dark place. Reconstituted solutions are aliquoted and frozen to avoid repeated freeze-thaw cycles.
Mass spectrometry is the usual confirmatory method because it measures the intact mass. Reversed-phase chromatography is used alongside it to estimate purity.
Not directly. Reported percentages depend on the chromatographic method, detection wavelength, and integration criteria, so the underlying method details matter.
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.